View of Improving treatment outcomes in chronic myeloid leukaemia patients using imatinib and artesunate combination therapy: a randomized controlled clinical trial protocol (IMART-trial)

Return to Article Details Improving treatment outcomes in chronic myeloid leukaemia patients using imatinib and artesunate combination therapy: a randomized controlled clinical trial protocol (IMART-trial) Download Download PDF